Dipharma is a global CDMO and leading manufacturer of APIs, NCEs and advanced intermediates for generic and contract manufacturing markets, offering about 40 APIs with DMFs registered worldwide. With around 600 skilled employees, four state-of-the-art cGMP facilities and two fully equipped R&D centers in the USA and Italy, the company has the scale and variety of capabilities to act as a global player while managing processes efficiently and flexibly.

コメントはありません。
評価とコメントを残す